Management of negative symptoms of schizophrenia
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 3 (5) , 413-417
Abstract
Persistent negative symptoms are a major cause of chronic disability in schizophrenia. The primary management approach for negative symptoms is use of atypical antipsychotics. Among atypical antipsychotics, clozapine produces the most robust reductions in negative symptoms. Lesser degrees of reduction are observed with risperidone and olanzapine. However, it remains unclear whether these agents treat core negative symptoms of schizophrenia, or simply induce less secondary psychopathology. A second approach for treatment of persistent negative symptoms is the use of N-methyl-D-aspartate (NMDA) receptor-stimulating agents, such as glycine, D-serine, or D-cycloserine. Significant benefit of these agents has been observed in combination with both conventional and newer atypical antipsychotics. Whether or not these agents are effective in combination with clozapine remains an open question, and large scale multicenter clinical trials are ongoing.Keywords
This publication has 39 references indexed in Scilit:
- Continuous Phencyclidine Treatment Induces Schizophrenia-Like Hyperreactivity of Striatal Dopamine ReleaseNeuropsychopharmacology, 2001
- A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2001
- Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized TrialsAmerican Journal of Psychiatry, 2001
- Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New HypothesisAmerican Journal of Psychiatry, 2001
- Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studiesJournal of Psychiatric Research, 2001
- Differentiating Primary From Secondary Negative Symptoms in Schizophrenia: A Study of Neuroleptic-Naive Patients Before and After TreatmentAmerican Journal of Psychiatry, 2000
- Comparative Efficacy of Risperidone and Clozapine in the Treatment of Patients With Refractory Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2000
- Intracortical Mechanisms of Mismatch Negativity Dysfunction in SchizophreniaAudiology and Neurotology, 2000
- Relationship of Cognitive Functioning, Adaptive Life Skills, and Negative Symptom Severity in Poor-Outcome Geriatric Schizophrenia PatientsThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical CorrelatesAmerican Journal of Psychiatry, 2000